HRS.15 Sessions to Attend
•
1 gefällt mir•1,015 views
This document provides a summary of 6 late-breaking sessions to attend at the Heart Rhythm Society Scientific Sessions in Boston from May 13-16, 2015. The sessions include: (1) a study on the impact of remote monitoring on clinical events and healthcare utilization; (2) a randomized global trial comparing uninterrupted rivaroxaban to vitamin K antagonists in patients undergoing catheter ablation; and (3) a study comparing cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation. The other sessions include: (4) first-in-human experience with a miniaturized transcatheter pacing system; (5) results from the Canadian Registry of Card
Empfohlen
Empfohlen
Weitere ähnliche Inhalte
Ähnlich wie HRS.15 Sessions to Attend
Ähnlich wie HRS.15 Sessions to Attend (20)
Mehr von Trimed Media Group
Mehr von Trimed Media Group (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
HRS.15 Sessions to Attend
- 1. Top 6 Late-Breaking Sessions to Attend at HRS.15 Heart Rhythm Society Scientific Sessions Wednesday, May 13 — Saturday, May 16, 2015 Boston, Massachusetts
- 2. (1) Thursday, May 14 1:30–1:45 pm, Ballroom West Impact of Remote Monitoring on Clinical Events & Healthcare Utilization: A Nationwide Assessment Jonathan P. Piccini, MD Duke University Medical Center Durham, N.C.
- 3. (2) Thursday, May 14 1:45–2:00 pm, Ballroom West VENTURE-AF: A Randomized Global Trial Evaluating Uninterrupted Rivaroxaban & Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Nonvalvular Atrial Fibrillation Andrea Natale, MD Texas Cardiac Arrhythmia Institute Austin, Texas
- 4. (3) Thursday, May 14 2:00–2:15 pm, Ballroom West Cryoballoon versus Open Irrigated Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study Dr. Armin Luik Städtisches Klinikum Karlsruhe Karlsruhe, Germany
- 5. (4) Friday, May 15 8:00–8:15 am, Ballroom West Performance of a Miniaturized Transcatheter Pacing System: First in-human Experience Philippe Ritter, MD Hopital Haut-Leveque Pessac, France
- 6. (5) Friday, May 15 8:30–8:45 am, Ballroom West Canadian Registry of Cardiac Implantable Electronic Device Outcomes: Phase 1 Riata Lead on Advisory (CREDO) Ratika Parkash, MD Queen Elizabeth II Health Sciences Centre at Dalhousie University Halifax, Nova Scotia
- 7. (6) Friday, May 15 9:15–9:30 am, Ballroom West Visually Guided Laser Balloon (VGLB) Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF): Results of the Prospective Multicenter Randomized Heartlight Study Vivek Y. Reddy, MD, Mount Sinai School of Medicine, New York, N.Y.